TRIAL MANAGEMENT
Clinical Trials And TMF 101 Learning Series: 2nd Session
The “Clinical Trials and TMF 101 Learning Series” kicks off it’s second session with three industry experts, that goes through some of the basics of clinical trials.
Solving The Impossible In Glioblastoma With An AI Synthetic Control Arm
This video discusses Medicenna’s MDNA55-05 clinical trial; a single-arm, open-label, multicenter study that offers a promising opportunity to improve outcomes for recurrent glioblastoma.
Lack Of IRT/RTSM System Reusability Surprises Every Clinical Trial Sponsor
Stop re-learning your IRT system with every new trial. Uncover why "standard" features often hide custom complexities that slow down UAT and clinical operations.
The Path Forward, Altasciences' Approach To Project Management
Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.
Say It With Technology: How Alnylam Fosters A Connected Relationship With Sites
Alnylam Pharmaceuticals is developing an entirely new class of medicines and delivered the world’s first and only approved RNAi therapeutics in 2018 and 2019. Learn how Alnylam earned its reputation among investigators as a sponsor of choice by standardizing studies...
Take A Look Inside The Pharmacodynamic Toolbox
This session explores the flexible selection of pharmacodynamic measures to enhance the pharmacology, safety, and efficacy evaluation of a CNS-active drug in early clinical trials.
The Golden Era Of GLP-1 Drugs
As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.
Perceptive eClinical
Learn about a randomization and trial supply management (RTSM) solution that helps keep your trial on track.
Clinical Research Without Borders
Explore strategies for navigating global clinical trials with, Afshawn Chakamian of Avidity Biosciences, Dr. Amy Raymond of Worldwide Clinical Trials, Scott Schliebner of Novotech, and Scout’s KimberLee Heidmann.
The Difference Between Clinical Trial Auditing And Monitoring
While both trial auditing and trial monitoring have the same goal of protecting participant safety and rights, they are two separate yet important pieces of the clinical trial process.
Practical Approaches To Faster Study Start-Ups
Learn how teams can leverage organizational, procedural, and technological solutions to recapture valuable days, weeks, and even months in the activation timelines of research sites.
Secrets To A Collaborative Model To Improve TMF Management
Speakers from Phlexglobal and Regeneron share the benefits of their highly effective partnering model and lessons learned that you can apply in your organization.
End-To-End Clinical Data Flow
Explore the interconnected data flow across Veeva Vault EDC, Veeva CDB, Veeva RTSM, and Veeva ePRO to visualize how these products work together seamlessly.
The Real Payoff Of Reusable IRT/RTSM System Design
By utilizing consistent, repeatable system builds, sponsors gain significant advantages during protocol amendments and operational changes.
Are Resource Constraints Impacting Your TMF Health?
Looking to quickly expand internal TMF resources with our anytime, anywhere TMF expertise? Unlock the potential to seamlessly access specialized TMF knowledge and support by viewing this presentation.
Disclosure As A Service ROI
How do sponsors determine the ROI of Disclosure as a Service? TrialScope talks with two sponsors – a large pharmaceutical company and a smaller biotech – for their take on this. Watch the short video.
Optimize Protocols For More Successful Trials
Find out how you can harness the power of AI and world-class data to recommend endpoints and inclusion/exclusion criteria for streamlined protocol design that results in more positive trial outcomes.
Yes, Your Study Is At Risk: Risk Mitigation Plans For Endpoints
Ocular endpoints often introduce unique bottlenecks that can stall enrollment and compromise data integrity. This presentation provides the tools for a streamlined, resilient clinical trial strategy.
Digital Physical Activity Measures In Phase 3 Immunology Trials
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
Exploring The Principles Integral To Rare Disease Drug Development
This on-demand webinar offers valuable insights into successful rare disease drug development, including study design, regulatory engagement, and market access strategy.
Navigating Early Phase CNS-Active Drug Development
Early development of CNS-active drugs requires in-depth clinical expertise. Altasciences’ Dr. Beatrice Setnik, Chief Scientific Officer, examines the strategies to ensure early comprehensive data collection to fulfill regulatory requirements and aid in evaluating th...
Keeping Up With ClinOps: Why And How To Improve Delivery
Industry experts discuss the concept of a trial platform as a service and how it can accelerate and enhance the day-to-day functions of clinical operations throughout the entire lifecycle of a study.
Webinar: Reimbursement Methods For Sustainable CGT Business Models
Learn more about the key features of successful innovative pricing and reimbursement models as well as outcomes-based agreements and the ways to advance those strategies for cell and gene therapies.
Early Planning Makes Clinical Research Meetings More Effective
Starting earlier can dramatically improve clinical research meetings. Explore how timing affects your choices and why identifying non-negotiables first helps teams manage meeting budgets.
Accelerate Your Data With Our Co-Located Clinic And Lab
Watch as we take your fresh sample from our clinic to PBMC separation. This video overviews our optimized workflows that ensure timely processing, transport, and analysis of your samples.
How RWD Reshapes Patient Recruitment Strategies
Discover how real-world data (RWD) is transforming patient recruitment by shifting from traditional site-centered methods to a patient-first approach.
Audit Trails: Demonstrating TMF Oversight, Completeness, & Accuracy
Listen in as experts share their knowledge and experience to provide insights on leveraging audit trails for oversight, completeness, and accuracy of TMF management systems.
Ensuring Compliance In Gene Therapy Trials: IRB And IBC Views
Explore ethical and regulatory challenges in neurological gene therapy trials, with expert insights on IRB/IBC collaboration, consent protocols, and oversight for vulnerable populations.
Investigator SmartSelect
This advanced recommendation engine identifies protocol-specific investigators in just minutes, dramatically shortening a process that typically takes four to six weeks.
Patient First Solutions For Oncology
Medable, Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting.